Ameriprise Financial Inc Altimmune, Inc. Transaction History
Ameriprise Financial Inc
- $364 Billion
- Q2 2024
A detailed history of Ameriprise Financial Inc transactions in Altimmune, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 3,223,997 shares of ALT stock, worth $21.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,223,997
Previous 1,709,304
88.61%
Holding current value
$21.7 Million
Previous $17.4 Million
23.21%
% of portfolio
0.01%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ALT
# of Institutions
189Shares Held
42.3MCall Options Held
1.05MPut Options Held
582K-
Black Rock Inc. New York, NY5.32MShares$35.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$33.1 Million0.0% of portfolio
-
State Street Corp Boston, MA3.91MShares$26.3 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$18.5 Million2.23% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA2.21MShares$14.9 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $330M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...